|
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
RECRUITINGSponsored by Société Algérienne de Formation et Recherche en Oncologie
Actively Recruiting
SponsorSociété Algérienne de Formation et Recherche en Oncologie
Started2025-07-21
Est. completion2026-07-21
Eligibility
Age19 Years+
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07484971
Summary
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer. It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Eligibility
Age: 19 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria: * Patients aged 19 years and older. * Diagnosis of prostate cancer confirmed histologically and/or biologically. * Patients followed in the participating oncology departments. * Written informed consent obtained. Non Inclusion Criteria: * Histological types other than carcinoma * Secondary tumors * Participation in an interventional study
Conditions7
CancerProstate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer (Diagnosis)Prostate Cancer (Post Prostatectomy)Prostate Cancer MetastaticProstate Cancer Patients Treated by Radiotherapy
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorSociété Algérienne de Formation et Recherche en Oncologie
Started2025-07-21
Est. completion2026-07-21
Eligibility
Age19 Years+
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07484971